InChI=1S/C20H28O4/c1- 2- 3- 6- 10- 17(21) 13- 14- 18- 16(12- 15- 19(18) 22) 9- 7- 4- 5- 8- 11- 20(23) 24/h3- 4,6- 7,12- 18,21H,2,5,8- 11H2,1H3,(H,23,24) /b6- 3- ,7- 4- ,14- 13+/t16- ,17- ,18+/m0/s1 |
DIBKBAMSPPKSTJ-BAILPSPNSA-N |
C(CCC(O)=O)/C=C\C[C@@H]1[C@H](C(C=C1)=O)/C=C/[C@H](C/C=C\CC)O |
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
(5Z)- 7- {(1S,5R)- 5- [(1E,3S,5Z)- 3- hydroxyocta- 1,5- dien- 1- yl]- 4- oxocyclopent- 2- en- 1- yl}hept- 5- enoic acid
|
(5Z,9Z,13E,15S,17Z)-15-hydroxy-11-oxoprostatetraenoic acid
|
ChEBI
|
15S-hydroxy-11-oxo-5Z,9Z,13E,17Z-prostatetraenoic acid
|
LIPID MAPS
|
PGJ3
|
SUBMITTER
|
22442337
|
PubMed citation
|
Europe PMC
|
26339618
|
PubMed citation
|
Europe PMC
|
|